Pulmatrix Receives $30,200,000 Series B Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=175b2c27-b665-4448-90b0-3a77f64aeed8&Preview=1 -
Date
11/2/2009 -
Company Name
Pulmatrix -
Mailing Address
99 Hayden Avenue Lexington, MA 02421 -
Company Description
Pulmatrix Inc. is a pharmaceutical company developing inhalable aerosols and enabling technologies that help control respiratory infectious disease and human-source airborne contamination. -
Website
http://www.pulmatrix.com -
Transaction Type
Venture Equity -
Transaction Amount
$30,200,000 -
Transaction Round
Series B -
Proceeds Purposes
Pulmatrix plans to use the new money to finance “multiple clinical trials” in 2010 and 2011 against a number of respiratory diseases, according to a company statement. -
M&A Terms
-
Venture Investor
ARCH Venture Partners -
Venture Investor
Novartis BioVenture Fund -
Venture Investor
Polaris Venture Partners -
Venture Investor
5AM Ventures
